Celldex Therapeutics
CLDX
CLDX
145 hedge funds and large institutions have $319M invested in Celldex Therapeutics in 2016 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 51 increasing their positions, 50 reducing their positions, and 46 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
77% less capital invested
Capital invested by funds: $1.39B → $319M (-$1.07B)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
145
Holding in Top 10
–
Calls
$3.97M
Puts
$3.68M
Top Buyers
| 1 | +$19.9M | |
| 2 | +$8.47M | |
| 3 | +$3.45M | |
| 4 |
Renaissance Technologies
New York
|
+$3.07M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$2.63M |
Top Sellers
| 1 | -$17.8M | |
| 2 | -$17.7M | |
| 3 | -$10.3M | |
| 4 |
Capital World Investors
Los Angeles,
California
|
-$9.83M |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$8.7M |